MDGEF Hisse Senedi Fiyat Grafiği
MDGEF Hisse Fiyat Tahmini
Medigene AG
$2.59
0%
$0
Kapanışta: May 13, 16:00:00 GMT-4
$2.59
0%
$0
Sonrası Piyasa: May 13, 16:43:13 GMT-4
Geri
Medigene AG (MDGEF) Hisse Fiyat Tahmini
Önemli İstatistikler
Önceki Kapanış
$2.59
Açılış fiyatı
$2.59
Günün Aralığı
$0.1 - $2.59
52 haftalık aralık
$0.1 - $2.59
İşlem hacmi
10.0K
Ort.Hacim
0
Dividend yield
--
EPS (TTM)
-1.28
Piyasa Değeri
$38.1M
MEDIGENE AG nedir?
MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. The company employs 86 full-time employees The company went IPO on 2000-06-30. The firm focuses on the development of personalized T cell-based immunotherapies. The company develops three platforms: T-cell receptor (TCR)-modified T cells for adoptive T-cell therapy as treatments for patients with tumor burdens; Dendritic cell (DC) vaccines for the treatment of low tumor burdens, such as minimal residual disease or for use in combination therapies, and T-cell-specific monoclonal antibodies (TABS) to identify T cells based on their T-cell receptors. The firm operates offices in Martinsried in Germany, as well as in Washington DC and San Diego in the United States.
